Apex Trials | Guelph, ON
Status
Conditions
Treatments
About
This randomized study will be conducted to compare the effect of a healthy beef-centric diet to a healthy U.S.-style dietary pattern on inflammation and other metabolic health outcomes in a metabolic syndrome and/or pre-diabetic population.
Full description
This study follows a randomized, open-label, parallel design to compare the effects of a healthy beef-centric diet to a healthy U.S.-style dietary pattern on inflammation and other metabolic health outcomes in a metabolic syndrome and/or pre-diabetic population.
The comparator diet in this study is a U.S. Department of Agriculture (USDA) Healthy U.S.-Style Dietary Pattern, as outlined in the 2020 Dietary Guidelines for Americans, which emphasizes the consumption of nutrient-dense foods across all food groups in recommended amounts. This includes a variety of vegetables, fruits, whole grains, low-fat dairy, lean protein sources, and healthy oils, while limiting added sugars, saturated fats, and sodium.
The test diet in this study involves a healthy beef-centric diet, where beef is the main source of protein. Participants will consume 70% of their daily energy intake from beef. The rest of their calories will come from other protein and fat sources (20%), along with a small amount (10%) from low-carbohydrate fruits (such as berries) and vegetables (like dark leafy greens). This diet excludes all grains. While the carbohydrate intake is low, it is slightly higher than that of a typical ketogenic diet.
The healthy beef-centric diet is being investigated for its effects on metabolic health after a 5 week intervention period. This study will investigate whether a beef-centric diet will support management of glycemic control, inflammation, and lipid-related risk factors, while also enhancing quality of life.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Participant must be 18 - 64 years of age (inclusive) at the time of signing the informed consent.
Have a BMI range of 25.0 - 39.9 kg/m2 (inclusive).
In otherwise generally good health as determined by the investigator.
Have blood hs-CRP levels equal to or greater than 2.0 mg/L at screening.
Have the following conditions at screening:
Pre-diabetes (defined as an HbA1c of 5.7-6.4% [inclusive]), and/or
MetS, i.e., have 3 of the 5 following metabolic criteria:
Report low levels of physical activity, as defined by a "low" activity classification on the IPAQ-SF.
Consume meat-based protein as a part of their normal diet and regularly consume beef.
Not currently using, defined as ≤ 3 uses in the past 3 months prior to Visit 2, any nicotine containing products (patches, gums, vapes, etc.), and willing to abstain for 14 days before Visit 2 until the last procedure.
Have maintained a stable, self-reported body weight for at least 6 months prior to screening (maximum ±10% change in self-reported body weight).
Willing and able to consume all aspects of either study dietary intervention.
Willing to adhere to all study dietary intervention prohibitions and restrictions.
Have maintained consistent dietary habits, including medication and supplement intake, and lifestyle for the last 3 months before screening and agree to maintain them throughout the study (unless required per the restrictions).
Agree to follow the restrictions on concomitant treatments.
Agree to follow the restrictions on lifestyle.
Agree to avoid pregnancy throughout the study if of childbearing potential by using any preferred contraceptive method.
Willing and able to agree to the requirements of this study, be willing to give voluntary consent, be able to understand and read the questionnaires, and carry out all study-related procedures.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
56 participants in 2 patient groups
Loading...
Central trial contact
Adam Kuttenkeuler; Stephanie Recker
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal